NCT02948881已完成4 期
A One Year, Parallel, Placebo-controlled, Double-blind, Randomized Study to Assess the Effect of Monthly 150mg Oral Ibandronate Dosing Versus Placebo on Bone Quality and Strength at the Proximal Femur in Women With Osteoporosis
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 16
- 主要终点
- Bone quality and strength at the hip by characterizing changes in trabecular and cortical bone quality using Volumetric Quantitative Computed Tomography (vQCT) and novel imaging analysis methods, including a subset of bone biopsies for one year.
研究概览
简要总结
The purpose of this study is to estimate the effect of oral Boniva (ibandronate sodium)taken once monthly versus placebo on bone quality and strength at the hip at one year.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 55 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Bone quality and strength at the hip by characterizing changes in trabecular and cortical bone quality using Volumetric Quantitative Computed Tomography (vQCT) and novel imaging analysis methods, including a subset of bone biopsies for one year.
时间窗: 1 Year
次要结局
- Relationship between biomarkers and changes in bone quality for one year.(1 Year)
研究者
研究点 (16)
Loading locations...
相似试验
终止
3 期
A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe PainPainBone NeoplasmNeoplasm MetastasisNCT00099177Hoffmann-La Roche96
已完成
4 期
A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With OsteopeniaPost-Menopausal OsteopeniaNCT00129623Hoffmann-La Roche160
已完成
2 期
Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)Irritable Bowel SyndromeNCT00761007Menarini Group554
已完成
3 期
A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.Post-Menopausal OsteopeniaNCT00545207Hoffmann-La Roche150
已完成
1 期
Drug-drug Interaction of Empagliflozin (BI 10773) and MicrogynonHealthyNCT01328184Boehringer Ingelheim18